GoHealth, Inc. (GOCO) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does GoHealth, Inc. Do?
GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois. GoHealth, Inc. (GOCO) is classified as a micro-cap stock in the Financials sector, specifically within the Insurance industry. The company is led by CEO Vijay Kotte and employs approximately 5,450 people. With a market capitalization of $22M, GOCO is one of the notable companies in the Financials sector.
GoHealth, Inc. (GOCO) Stock Rating — Avoid (April 2026)
As of April 2026, GoHealth, Inc. receives a Avoid rating with a composite score of 20.5/100 and 1 out of 5 stars from the Blank Capital Research quantitative model.GOCO ranks #4,403 out of 4,446 stocks in our coverage universe. Within the Financials sector, GoHealth, Inc. ranks #889 of 891 stocks, placing it in the lower half of its Financials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
GOCO Stock Price and 52-Week Range
GoHealth, Inc. (GOCO) currently trades at $1.05. The stock lost $0.00 (0.0%) in the most recent trading session. The 52-week high for GOCO is $14.14, which means the stock is currently trading -92.6% from its annual peak. The 52-week low is $1.31, putting the stock -19.9% above its annual trough. Recent trading volume was 21K shares, suggesting relatively thin trading activity.
Is GOCO Overvalued or Undervalued? — Valuation Analysis
GoHealth, Inc. (GOCO) carries a value factor score of 11/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 2.82x, versus the sector average of 1.22x. The price-to-sales ratio is 0.04x, compared to 0.90x for the average Financials stock.
At current multiples, GoHealth, Inc. trades at a premium to most Financials peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.
GoHealth, Inc. Profitability — ROE, Margins, and Quality Score
GoHealth, Inc. (GOCO) earns a quality factor score of 20/100, signaling below-average profitability metrics relative to the broader market. Return on assets (ROA) comes in at -43.0% versus the sector average of 1.2%.
On a margin basis, GoHealth, Inc. reports gross margins of 68.1%. The operating margin is -245.2% (sector: 21.8%). Net profit margin stands at -258.3%, versus 17.7% for the average Financials stock. Revenue growth is running at -67.7% on a trailing basis, compared to 9.4% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.
GOCO Debt, Balance Sheet, and Financial Health
GoHealth, Inc. has a debt-to-equity ratio of 1222.0%, compared to the Financials sector average of 121.0%. This elevated leverage warrants close monitoring, as it increases the company's sensitivity to rising interest rates and economic downturns. The current ratio is 2.02x, indicating strong short-term liquidity. Total debt on the balance sheet is $637M. Cash and equivalents stand at $32M.
GOCO has a beta of 1.39, meaning it is more volatile than the broader market — a $10,000 investment in GOCO would be expected to move 39.0% more than the S&P 500 on any given day. The stability factor score for GoHealth, Inc. is 21/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.
GoHealth, Inc. Revenue and Earnings History — Quarterly Trend
In TTM 2026, GoHealth, Inc. reported revenue of $467M and earnings per share (EPS) of $-20.17. Net income for the quarter was $-424M. Gross margin was 68.1%. Operating income came in at $-423M.
In FY 2025, GoHealth, Inc. reported revenue of $362M and earnings per share (EPS) of $-20.17. Net income for the quarter was $-498M. Gross margin was 73.4%. Revenue grew -54.8% year-over-year compared to FY 2024. Operating income came in at $-413M.
In Q3 2025, GoHealth, Inc. reported revenue of $34M and earnings per share (EPS) of $-11.80. Net income for the quarter was $-314M. Gross margin was 41.2%. Revenue grew -71.1% year-over-year compared to Q3 2024. Operating income came in at $-288M.
In Q2 2025, GoHealth, Inc. reported revenue of $94M and earnings per share (EPS) of $-5.10. Net income for the quarter was $-116M. Gross margin was 65.5%. Revenue grew -11.2% year-over-year compared to Q2 2024. Operating income came in at $-99M.
Over the past 8 quarters, GoHealth, Inc. has demonstrated a growth trajectory, with revenue expanding from $106M to $467M. Investors analyzing GOCO stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
GOCO Dividend Yield and Income Analysis
GoHealth, Inc. (GOCO) does not currently pay a dividend. This is common among smaller companies in the Insurance industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Financials dividend stocks may want to explore other Financials stocks or use the stock screener to filter by dividend yield.
GOCO Momentum and Technical Analysis Profile
GoHealth, Inc. (GOCO) has a momentum factor score of 8/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 39/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 50/100 reflects moderate short selling activity.
GOCO vs Competitors — Financials Sector Ranking and Peer Comparison
Within the Financials sector, GoHealth, Inc. (GOCO) ranks #889 out of 891 stocks based on the Blank Capital composite score. This places GOCO in the lower half of all Financials stocks in our coverage universe. Key competitors and sector peers include WHITE MOUNTAINS INSURANCE GROUP LTD (WTM) with a score of 62.9/100, OPPENHEIMER HOLDINGS INC (OPY) with a score of 62.6/100, Enact Holdings, Inc. (ACT) with a score of 61.6/100, International General Insurance Holdings Ltd. (IGIC) with a score of 61.3/100, and PARKE BANCORP, INC. (PKBK) with a score of 60.4/100.
Comparing GOCO against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full GOCO vs S&P 500 (SPY) comparison to assess how GoHealth, Inc. stacks up against the broader market across all factor dimensions.
GOCO Next Earnings Date
No upcoming earnings date has been announced for GoHealth, Inc. (GOCO) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy GOCO? — Investment Thesis Summary
The quantitative profile for GoHealth, Inc. suggests caution. The quality score of 20/100 flags below-average profitability. The value score of 11/100 indicates premium valuation. Momentum is weak at 8/100, a headwind for near-term performance. High volatility (stability score 21/100) increases portfolio risk.
In summary, GoHealth, Inc. (GOCO) earns a Avoid rating with a composite score of 20.5/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on GOCO stock.
Related Resources for GOCO Investors
Explore more research and tools: GOCO vs S&P 500 comparison, top Financials stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare GOCO head-to-head with peers: GOCO vs WTM, GOCO vs OPY, GOCO vs ACT.